Effect of Caudal Nalbuphine on Postoperative Analgesia in Children

Assiut University

Status: Completed

Conditions: Postoperative Pain

Treatments: Drug: Bupivacaine; Drug: Nalbuphine plus Bupivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT02618876

IRB 000087145

Details and patient eligibility

About

Nalbuphine as an adjuvant to bupivacaine caudal anesthesia for postoperative analgesia in children undergoing Hypospadias repair.

2 groups, 30 patients each

Enrollment: 60 patients

Sex: Male

Ages: 2 to 10 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children undergoing elective Hypospadias repair
• with American Society of Anesthesiologists (ASA) physical status I
• age 2-10 years

Exclusion criteria

• Coagulation disorder
• allergy to study medications
• major malformations of the lower spine or meninges or any cutaneous or subcutaneous lesion at the site of injection.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

60 participants in 2 patient groups

Nalbuphine group

Active Comparator group

Description:

30 children will be given Caudal Bupivacaine plus Nalbuphine.

Treatment:

Drug: Nalbuphine plus Bupivacaine

Control group

Other group

Description:

30 children will be given Caudal Bupivacaine.

Treatment:

Drug: Bupivacaine